# EDGAR Filing Document

**Accession Number:** 0001633061
**File Stem:** 0000894189-25-016102
**Filing Date:** 2025-11
**Character Count:** 11052
**Document Hash:** 45d7f59748ad034351b230179e321e0d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000894189-25-016102.hdr.sgml**: 20251126

**ACCESSION NUMBER**: 0000894189-25-016102

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251126

**DATE AS OF CHANGE**: 20251126

**PERIOD START**: 20250930

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Amplify ETF Trust
- **CENTRAL INDEX KEY:** 0001633061

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23108
- **FILM NUMBER:** 251530352

**BUSINESS ADDRESS:**
- **STREET 1:** 310 S. HALE ST.
- **CITY:** WHEATON
- **STATE:** IL
- **ZIP:** 60187
- **BUSINESS PHONE:** (630)869-0202

**MAIL ADDRESS:**
- **STREET 1:** 310 S. HALE ST.
- **CITY:** WHEATON
- **STATE:** IL
- **ZIP:** 60187

## Series and Classes Contracts Data

### Amplify Weight Loss Drug & Treatment ETF (Series ID: S000085024)

| Class ID   | Class Name                               | Ticker Symbol   |
|:---|:---|:---|
| C000249887 | Amplify Weight Loss Drug & Treatment ETF |  |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Amplify ETF Trust

- **b. Investment Company Act file number:** 811-23108

- **c. CIK number of Registrant:** 0001633061

- **d. LEI of Registrant:** 5493006EMX6222CPWJ71

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 3333 Warrenville Road

  - **City:** Lisle

  - **State:** IL

  - **Foreign country:** US

  - **Zip / Postal Code:** 60532

  - **Telephone number:** 855-267-3837

**Item A.2. Information about the Series.**

- **a. Name of Series:** Amplify Weight Loss Drug & Treatment ETF

- **b. EDGAR series identifier (if any):** S000085024

- **c. LEI of Series:** 52990078J44DANY0H471

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-09-30

- **b. Date as of which information is reported:** 2025-09-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $3102734.22

**Total Liabilities:** $51440.53

**Net Assets:** $3051293.69

**Cash Not Reported:** $0.63

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000249887 | -0.63%               | 2.16%                | 2.09%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-63.61                  | $-21793.28                                 |
| Month 2  | $-183.10                 | $97782.60                                  |
| Month 3  | $93009.45                | $-14357.23                                 |

**Designated Index Information**

- **Index Name:** N/A

- **Index Identifier:** N/A

### Schedule of Portfolio Investments

| Name                           | Title                                              | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Merck & Co Inc                 | Merck & Co Inc                                     | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |      1758 | NS      | $147548.94    | 4.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Metsera Inc                    | Metsera Inc                                        | CUSIP: 59267L107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       959 | NS      | $50184.47     | 1.64%             |  |  |  | No            |                  1 | On Loan: —       |
| Invesco Government & Agency Po | Invesco Government & Agency Portfolio              | CUSIP: 825252885<br>LEI: 5493007T1J7WZ5QI1A47 | Long             | STIV             | RF                | US        |     71586 | NS      | $71586.43     | 2.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Jiangsu Hengrui Pharmaceutical | Jiangsu Hengrui Pharmaceuticals Co Ltd             | CUSIP: N/A<br>LEI: 2549003BT1XS3SE3E448       | Long             | EC               | CORP              | CN        |      5000 | NS      | $57066.47     | 1.87%             |  |  |  | No            |                  1 | On Loan: No      |
| AbbVie Inc                     | AbbVie Inc                                         | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |       621 | NS      | $143786.34    | 4.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                      | Amgen Inc                                          | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |       706 | NS      | $199233.20    | 6.53%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                | AstraZeneca PLC                                    | CUSIP: 046353108<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |      1846 | NS      | $141625.12    | 4.64%             |  |  |  | No            |                  1 | On Loan: No      |
| First American Government Obli | First American Government Obligations Fund         | CUSIP: 31846V336<br>LEI: 549300R5MYM6VZF1RM44 | Long             | STIV             | RF                | US        |     49522 | NS      | $49522.50     | 1.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Hims & Hers Health Inc         | Hims & Hers Health Inc                             | CUSIP: 433000106<br>LEI: 254900V041EIVTSB6D58 | Long             | EC               | CORP              | US        |      2362 | NS      | $133972.64    | 4.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                 | Eli Lilly & Co                                     | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |       495 | NS      | $377685.00    | 12.38%            |  |  |  | No            |                  1 | On Loan: No      |
| CSPC Pharmaceutical Group Ltd  | CSPC Pharmaceutical Group Ltd                      | CUSIP: N/A<br>LEI: 529900M3XQCW234H8O91       | Long             | EC               | CORP              | CN        |    116000 | NS      | $139699.76    | 4.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Chugai Pharmaceutical Co Ltd   | Chugai Pharmaceutical Co Ltd                       | CUSIP: N/A<br>LEI: 529900T9LAII161DCN95       | Long             | EC               | CORP              | JP        |      4400 | NS      | $192106.17    | 6.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S               | Novo Nordisk A/S                                   | CUSIP: 670100205<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |      6892 | NS      | $382437.08    | 12.53%            |  |  |  | No            |                  1 | On Loan: No      |
| Shionogi & Co Ltd              | Shionogi & Co Ltd                                  | CUSIP: N/A<br>LEI: 35380049VXDTHZI3DY35       | Long             | EC               | CORP              | JP        |      7700 | NS      | $135115.62    | 4.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG               | Roche Holding AG                                   | CUSIP: N/A<br>LEI: 549300U41AUUVOAAOB37       | Long             | EC               | CORP              | CH        |       429 | NS      | $140133.35    | 4.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc                     | Pfizer Inc                                         | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |      5749 | NS      | $146484.52    | 4.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc  | Regeneron Pharmaceuticals Inc                      | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |       351 | NS      | $197356.77    | 6.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Scholar Rock Holding Corp      | Scholar Rock Holding Corp                          | CUSIP: 80706P103<br>LEI: 549300Z1FLPGL4OWJ459 | Long             | EC               | CORP              | US        |      1526 | NS      | $56828.24     | 1.86%             |  |  |  | No            |                  1 | On Loan: No      |
| Zealand Pharma A/S             | Zealand Pharma A/S                                 | CUSIP: N/A<br>LEI: 549300ITBB1ULBL4CZ12       | Long             | EC               | CORP              | DK        |      1309 | NS      | $95010.06     | 3.11%             |  |  |  | No            |                  1 | On Loan: No      |
| UNITED LAB                     | United Laboratories International Holdings Ltd/The | CUSIP: N/A<br>LEI: 2549007JL3XIH77JXN70       | Long             | EC               | CORP              | HK        |     22000 | NS      | $42470.82     | 1.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Hanmi Pharm Co Ltd             | Hanmi Pharm Co Ltd                                 | CUSIP: N/A<br>LEI: 988400PP10VZVUOFE672       | Long             | EC               | CORP              | KR        |       128 | NS      | $33481.34     | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Innovent Biologics Inc         | Innovent Biologics Inc                             | CUSIP: N/A<br>LEI: 25490058ONL9SCIE1R22       | Long             | EC               | CORP              | CN        |     11500 | NS      | $142486.25    | 4.67%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2025-11-07

**Name of Applicant:** Amplify ETF Trust

**Signature:** /s/ Bradley H. Bailey

**Name of Signer:** Amplify ETF Trust

**Title:** Principal Financial Officer